- AI in PV
- AI Implementation
- AI Training
- AI Compliance
- Regional Coverage
- Expertise
- QPPV Services
- Aggregate Reports
- Signal and Risk Management
- Audits and Due Diligence
- Training and Consultancy
- Digital Transformation
- Technology
iVigee is a leading pharmacovigilance service provider working with a range of pharmaceutical and biotech organizations globally. Here is where you can stay up-to-date with news stories involving iVigee and team members
iVigee. Speaking, showing, and leading at DIA Europe 2024. We are proud to be exhibiting at booth D5 at this year’s DIA Europe conference in Brussels from the 12th to the 14th of March. And we’ll be demonstrating our thought leadership from the top with CEO Jan Petracek co-chairing the Wednesday 13th track 07 Pharmacovigilance and Safety session - How to build a sustainable Pharmacovigilance Ecosystem?
Where will AI take YOU in 2024?
As we wrap up DIA Baltimore and set our sights on DIA Europe in Brussels, it’s clear from the feedback we got from attendees on our AI in PV products, the PV community is laser focused on implementing AI at their organisations in a safe and practical manner…
Richard Barfield joins the iVigee Board as Non-Executive Director.
iVigee - Platinum Sponsors at DIA Global Pharmacovigilance Conference.
This years Global Pharmacovigilance and Risk Management Strategies Conference runs from February 5th to the 7th at the Baltimore Marriott Waterfront, and iVigee are proud to be Platinum sponsors of the event, located at booth #200.
iVigee to deliver 2nd run of the successful AI in PV training course for DIA in January. There are just 3 weeks to go until the Drug Information Association runs its comprehensive practical orientation course on AI in Pharmacovigilance, delivered by iVigee Jan Petracek and Robert Scheiner, and the UK MHRA 2019s Deputy Director - Patient Safety Monitoring Phil Tregunno.
iVigee 2023 milestones. We 2019ve had a few!
As 2023 draws to a close, it a good time to review some of iVigee 2019 s key successes and look back over what has been a tremendous year of innovation and growth for us, captured in this post 2019s slideshow.
iVigee launches breakthrough iViReg Community subscription package!
Pharmacovigilance professionals can now gain access to our world-leading iViReg platform through a simple online entry-level subscription, allowing them to access core features of iViReg in one easy step.
This year marked significant strides in AI, with leading regulatory bodies inviting public commentary on their perspectives regarding AI and Machine Learning (AI/ML) in drug development. While the FDA's consultation period concluded earlier in August (find the paper here), the EMA's window remains open until year-end.